期刊文献+

降钙素原与血流感染相关性 被引量:2

The Association of Procalcitonin and Bloodstream Infectious
下载PDF
导出
摘要 目的:探讨降钙素原(PCT)检测在血液感染性疾病中的诊断价值。方法:选择2014年5月-2015年5月笔者所在医院同时检测PCT和血培养的患者377例,分析比较其检测结果。结果:血培养阳性患者PCT送检率27.45%;血培养阳性组的PCT阳性率41.4%,高于血培养阴性组的11.7%,差异有统计学意义(P<0.05);血培养鉴定出革兰阴性菌的患者PCT中位数15.54 ng/ml,明显高于革兰阳性菌患者的0.14 ng/ml,差异有统计学意义(P<0.05).结论:血清PCT检测有助于细菌性血流感染的诊断,其检测方法简便、可靠,值得临床推广应用。 Objective: To explore the application value of procalcitonin(PCT) in blood infectious disease.Method: 377 patients who received the examination of PCT and blood culture in our hospital from May 2014 to May 2015 were selected.The testing results were analyzed.Result: PCT examination rate in the positive blood culture was 27.45%.The PCT positive rate of the positive blood culture group was 41.4%, higher than 11.7% of the negative blood culture group, the difference was statistically signifieant(P〈0.05).The median level of serum PCT was 15.54 ng/ml in gram-negative bacteria, higher than 0.14 ng/ml in gram-positivebacteria, the difference was statistically significant(P〈0.05).Conclusion: Serum PCT can help the diagnosis of bacterial bloodstream infeetions, its detection method is simple and reliable, which is worthy of clinical popularization and application.
作者 聂立岩
出处 《中外医学研究》 2016年第15期14-15,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 血流感染 降钙素原 血培养 Bloodstream infections Procalcitonin Blood culture
  • 相关文献

参考文献7

二级参考文献48

  • 1胡如雪.降钙素原(PCT)的临床应用价值[J].江西医学检验,2005,23(3):259-259. 被引量:39
  • 2Dikekema DJ, Beekmann SE, Chapin KC, et al. Epidemiology and outcome of nosocomial and community-onset bloodstream infeetion[J]. J Clin Microbiol, 2003, 41(8) :3655 3660.
  • 3Diekema DJ, Pfaller MA, Jones RN, et al. Survey of blood- stream infections due to grain negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997[J] Clin Infect Dis, 1999,29(3) :595-607.
  • 4Rodriguez-Bafio J, de Cueto M, Retamar P, et al. Current management of bloodstream infections[J]. Expert Rev Anti Infect Ther, 2010, 8(7): 815-829.
  • 5Schwaber MJ, Carmeli Y. Carbapenem-resistant Enterobae- teriaeeae: a potential threat[J]. JAMA, 2008, 300(24): 2911 2913.
  • 6Fishbain J, Peleg AY. Treatment of Acinetobacter infections[J]. ClinInfect Dis, 2010, 51(1):79 84.
  • 7Kumar A, Roberts D, Wood KE, etal. Duration of hypoten- sion before initiation of effective antimierobial therapy is the critical determinant of survival in human septic shock[J] Crit Care Med, 2006, 34: 1589-1596.
  • 8Tang BM. , Eslick GD, Craig JC, etal . Accuracy of procalci tonin for sepsis diagnosis in critically ill patients: systematic review and recta-analysis[J]. Lancet Infectious Diseases, 2007, 7(3): 210-217.
  • 9Reinhart K, Meisner M, Brunkhorst FM. Markers for sepsis diagnosis: what is useful[J]. Crit Care Clin, 2006, 22(3): 508-519.
  • 10Azevedo JR, Torres OJ, Czeczko NG, et al. Procalcitonin as e a prognostic biomarker of severe sepsis and septic shock[J]. Rev Col Bras Cir,2012,39(6) :456-461.

共引文献157

同被引文献9

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部